Primary myeloma interaction and growth in coculture with healthy donor hematopoietic bone marrow

Por Bam, Rakesh, Khan, Sharmin, Ling, Wen, Randal, Shelton S., Li, Xin, Barlogie, Bart, Edmondson, Ricky, Yaccoby, Shmuel
Publicado no BMC Cancer (2015)

CYR61/CCN1 overexpression in the myeloma microenvironment is associated with superior survival and reduced bone disease

Por Johnson, Sarah K., Stewart, James P., Bam, Rakesh, Qu, Pingping, Barlogie, Bart, van Rhee, Frits, Shaughnessy, John D., Epstein, Joshua, Yaccoby, Shmuel
Publicado em 2014

NAMPT/PBEF1 enzymatic activity is indispensable for myeloma cell growth and osteoclast activity

Por Venkateshaiah, Sathisha Upparahalli, Khan, Sharmin, Ling, Wen, Bam, Rakesh, Li, Xin, van Rhee, Frits, Usmani, Saad, Barlogie, Bart, Epstein, Joshua, Yaccoby, Shmuel
Publicado no Exp Hematol (2013)

Role of Bruton’s tyrosine kinase in myeloma cell migration and induction of bone disease

Por Bam, Rakesh, Ling, Wen, Khan, Sharmin, Pennisi, Angela, Venkateshaiah, Sathisha Upparahalli, Li, Xin, van Rhee, Frits, Usmani, Saad, Barlogie, Bart, Shaughnessy, John, Epstein, Joshua, Yaccoby, Shmuel
Publicado em 2013

Identification of Doxorubicin as an Inhibitor of the IRE1α-XBP1 Axis of the Unfolded Protein Response

Por Jiang, Dadi, Lynch, Connor, Medeiros, Bruno C., Liedtke, Michaela, Bam, Rakesh, Tam, Arvin B., Yang, Zhifen, Alagappan, Muthuraman, Abidi, Parveen, Le, Quynh-Thu, Giaccia, Amato J., Denko, Nicholas C., Niwa, Maho, Koong, Albert C.
Publicado no Sci Rep (2016)